I would love to know as well…are you using your erp solely or is it interfacing with a ctms?

What are your workday challenges.

________________________________
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> on behalf of Malik F. Olanrewaju <xxxxxx@uw.edu>
Sent: Wednesday, October 1, 2025 8:47 AM
To: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org>
Subject: [EXTERNAL] RE: [RESADM-L] What financial system does your university use for Clinical Trials?

This Message Is From an External Sender
This message came from outside your organization.
Report Suspicious<https://us-phishalarm-ewt.proofpoint.com/EWT/v1/DCTxO5nwB6A69OQV!P-r6VaCkI5TWp38dz8HPihgijtwDgg9ztyAAWE6Wu7oiL0MSLQB0Nd6uWu6w2Kk5rj8NIKRdpDz9bv9T1r603JTTGMmlwje8LP1epqE8BeSnPct3Kq1456mD5mQz8T2b8sIHyPkqxE2wMk9i$>

**WARNING** DO NOT CLICK links or attachments unless you recognize the sender: xxxxxx@lists.healthresearch.org.

________________________________
Hey Hallie,

Could you let me know the challenges you are running into with financial tracking for Clinical Trials in Workday? Maybe top three you are wanting to address?

Thanks

Malik Olanrewaju |
MAA  | Senior Analyst
Management Accounting & Analysis
4320 Brooklyn Ave NE  | Suite 5  | Seattle, WA 98195
OFFICE:   EMAIL: xxxxxx@uw.edu<mailto:xxxxxx@uw.edu>    WEBSITE: finance.uw.edu/maa
Fax: 206 685 9197

From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> On Behalf Of Hallie Lyons
Sent: Monday, September 29, 2025 2:33 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] What financial system does your university use for Clinical Trials?

Happy Monday!
We have been using Workday for Clinical Trials and it is NOT working.  Do any of you use Workday for Clinical Trials?  If not, what financial/tracking system do you use that works well?

Thank you!

[UNLV Logo]<https://urldefense.com/v3/__http:/unlv.edu/__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIMCSuCG1g$>

Hallie Lyons, CRA
Associate Director, Grants and Contracts
Office of Sponsored Programs
University of Nevada, Las Vegas

4505 Maryland Parkway

Las Vegas, NV 89154-1055

xxxxxx@unlv.edu<mailto:xxxxxx@unlv.edu>
Main: 702-895-1357<tel:17028951357> Direct: 702-895-3104<tel:17028953104>

Web<https://urldefense.com/v3/__https:/unlv.edu/research/osp__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIPfrsIp7g$> • Twitter<https://urldefense.com/v3/__http:/twitter.com/unlv__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgINXi4RCsQ$> • Facebook<https://urldefense.com/v3/__https:/www.facebook.com/OfficialUNLV__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIOeKWqQQQ$> • Instagram<https://urldefense.com/v3/__http:/instagram.com/unlv__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIMn3MJUIA$> • YouTube<https://urldefense.com/v3/__https:/www.youtube.com/unlvofficial__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIOlK-PpHw$>

*OSP will respond to emails within 3 business days.  If you need immediate assistance, please call any of the phone numbers listed above*

PUBLIC RECORDS NOTICE: In accordance with NRS Chapter 239, this email and responses, unless otherwise made confidential by law, may be subject to the Nevada Public Records laws and may be disclosed to the public upon request.

- = - = - = - = - = - = -

This email was sent to xxxxxx@uw.edu<mailto:xxxxxx@uw.edu> via the Research Administrator's mailing list.

To unsubscribe from RESADM-L, go to https://lists.healthresearch.org<https://urldefense.com/v3/__https:/lists.healthresearch.org__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIN7k6DpDw$> and enter your subscribed email address into the "My account and unsubscriptions" area at the bottom of the page. This also allows you to switch to Digest Mode or to temporarily suspend emails. You will be emailed a link to change all these settings.

List archives are available at: https://lists.healthresearch.org/resadm-l<https://urldefense.com/v3/__https:/lists.healthresearch.org/resadm-l__;!!K-Hz7m0Vt54!nOzxbpFIIDi-WV69r-2rvBWQ-MqCQkrPKcUmu-9EPfbWYtNP5BRX8hA0qI1a8YflR3SDvAO_KaSZgIO6m030Ug$>

Please keep in mind that responses are copied verbatim to 10,000+ users - - please refrain from "Me Too"s and clicking on reactions to emails. That will keep your email environment clean. Thanks!

- = - = - = - = - = - = -

This email was sent to xxxxxx@phoenixchildrens.com via the Research Administrator's mailing list.

To unsubscribe from RESADM-L, go to https://lists.healthresearch.org<https://urldefense.com/v3/__https://lists.healthresearch.org__;!!DCTxO5nwB6A69OQV!0sDGtBHR4W-2994hNOXuuVdMRWPWDRMi2RPEwk6NHN_tT9CbQsKvXE1G_kOGP5y_ggoIG54zjSFFGB5Df7o$> and enter your subscribed email address into the "My account and unsubscriptions" area at the bottom of the page. This also allows you to switch to Digest Mode or to temporarily suspend emails. You will be emailed a link to change all these settings.

List archives are available at: https://lists.healthresearch.org/resadm-l<https://urldefense.com/v3/__https://lists.healthresearch.org/resadm-l__;!!DCTxO5nwB6A69OQV!0sDGtBHR4W-2994hNOXuuVdMRWPWDRMi2RPEwk6NHN_tT9CbQsKvXE1G_kOGP5y_ggoIG54zjSFFOclpcoo$>

Please keep in mind that responses are copied verbatim to 10,000+ users - - please refrain from "Me Too"s and clicking on reactions to emails. That will keep your email environment clean. Thanks!

**********************************************************************

This transmission, including any attachments, is for the sole use of the intended recipient(s) and may contain information that is confidential, proprietary, legally privileged, or otherwise protected by law from disclosure. Any unauthorized review, use, copying, disclosure, or distribution is prohibited. If you are not the intended recipient, or the person responsible for delivering this to an addressee, you should notify the sender immediately by telephone or by reply e-mail, and destroy all copies of the original message.